AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 43 min read$CLOV

Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect

Clover Health (NASDAQ: CLOV) will report earnings Wednesday after market close. The company last quarter reported revenue of $749.2 million, up 62% year on year, and added 41,970 customers to 155,773. Analysts expect this quarter’s revenue to rise 52.5% y/y. The article cites an average analyst price target of $4.58 versus a $4.35 share price.

Original reporting
financialcontent.com
Published Aug 4, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 4:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect — source image
Source · financialcontent.com
Decision brief

The 30-second read

$CLOVNeutralMed
01

Why it matters

Traders can use the stated consensus growth rate and the company’s recent revenue-miss history to form scenarios for the earnings reaction, but there is no new company-specific disclosure beyond the scheduled reporting date.

02

Market read

This is primarily an earnings preview with consensus and peer read-across, useful for positioning into the print.

03

What to watch

The article notes multiple recent revenue misses but does not quantify how consensus is positioned versus prior misses, which can drive earnings-day positioning and implied volatility.

Relevance 4/10Novelty 4/10Timing: after-market-close earnings scheduled for Wednesday

Background

The piece frames Clover Health’s upcoming earnings release and summarizes the prior quarter’s performance plus consensus expectations for the current quarter.

Company-level read

Ticker impact

$CLOVNeutralMedium confidence
Context

Clover Health is scheduled to report earnings after the close, with the article citing consensus revenue growth and recent estimate reconfirmations.

Expected impact

Likely volatility around the print, with direction dependent on whether revenue growth and any updated guidance beat or miss expectations.

Evidence & confidence

The newest concrete facts are the earnings timing and the stated consensus/expectations; there is no new guidance, filing, or surprise event disclosed in the text.

Market effects

Sector

Peer results (Centene, UnitedHealth) are used as a read-across, but the article does not introduce new sector policy or regulatory developments.

Regional

None specified.

Global

None specified.

Counterpoint

What could challenge this read

If the market has already priced in a continuation of recent growth trends, the stock could react more to guidance quality (EBITDA/EPS trajectory) than to revenue growth alone.

Key entities

  • company
    Clover Health

    NASDAQ-listed health insurer reporting earnings after the close on Wednesday.

  • company
    Centene

    Peer cited for Q2 results as a read-across (revenue growth and post-results move).

  • company
    UnitedHealth

    Peer cited for Q2 results as a read-across (flat revenue and post-results move).

Read at source← All news

Related articles

AUG 7
$CLOVMedAI 8/10

Clover Health Investments Q2 Earnings Call Highlights

Clover Health Investments (CLOV) reported Q2 adjusted EBITDA of $41 million and GAAP net income of $28 million. For the first half of 2026, it posted $81 million adjusted EBITDA and $55 million GAAP net income, with $443 million cash and investments and no debt. The company raised 2026 guidance to $2.92B-$3.0B revenue and $70M-$85M adjusted EBITDA, and discussed cohort maturation and 4.5-star ratings for 2027.

yahoo.com6 min
AUG 6
$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

insurancebusinessmag.com9 min
AUG 5
$CLOVHighAI 9/10

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV): Results of Operations and Financial Condition

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q26exx991xearningsrelease.htm EX-99.1 Document Exhibit 99.1 Clover Health Reports Second Quarter 2026 Results Business Highlights: • Delivered strong second quarter 2026 GAAP Net Income alongside continued market-leading Medicare Advantage membership growth • Improved

SEC EDGAR 8-K6 min
JUL 24
$CLOVMed

What's Fueling Clover Health's Recent Stock Surge

Clover Health (CLOV) shares rose about 7% to $2.39 after UnitedHealth Group (UNH) reported strong Q1 2026 results and raised its full-year adjusted net earnings outlook to over $18.25 per share, lifting sentiment for health insurers. Clover also cited 53% YoY Medicare Advantage membership growth and reiterated 2026 GAAP net income profitability guidance. Analysts maintain a Hold rating and a $2.90 average target.

kavout.com4 min